Reference interval for serum C-reactive protein in healthy blood donors using the Dade Behring N Latex CRP mono assay

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 60, Issue 1, 2000, Pages 37-43

  Erlandsen, Erland J ^a   Randers, E ^a  

^a VIBORG HOSPITAL   (Denmark)

Author keywords

Acute phase protein; C reactive protein; Immunoassay; Reference values

Indexed keywords

ACUTE PHASE PROTEIN; BILIRUBIN; C REACTIVE PROTEIN; HEMOGLOBIN; INTRALIPID;

ACCURACY; ADULT; ARTICLE; CONTROLLED STUDY; DEVICE; FEMALE; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; IMMUNOASSAY; MALE; NEPHELOMETRY; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REFERENCE VALUE; SEX DIFFERENCE;

EID: 0034106487     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365510050185029     Document Type: Article

References (25)

1. 1 Pepys MB. C-reactive protein fifty years on. Lancet 1981; 653-7.
2. 2 Pepys MB, Baltz ML. Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. Adv Immunol 1983; 34: 141-212.
3. 3 Grützmeier S, von Schenck H. Four immuno-chemical methods for measuring C-reactive protein in plasma compared. Clin Chem 1989; 35: 461-3.
4. 4 Thompson D, Milford-Ward A, Whicher JT. The value of acute phase protein measurements in clinical practice. Ann Clin Biochem 1992; 29: 123-31.
5. 5 Keevil BG, Nicholls SP, Kilpatrick ES. Evaluation of a latex-enhanced immunoturbidimetric assay for measuring low concentrations of C-reactive proteins. Ann Clin Biochem 1998; 35: 671-3.
6. 6 Macy EM, Hayes TE, Tracy RP. Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. Clin Chem 1997; 43: 52-8.
7. 7 Wilkins J, Gallimore JR, Moore EG, Pepys MB. Rapid automated high sensitivity enzyme immunoassay of C-reactive protein. Clin Chem 1998; 44: 1358-61.
8. 8 Eda S, Kaufmann J, Roos W, Pohl S. Development of a new microparticle-enhanced turbidimetric assay for C-reactive protein with superior features in analytical sensitivity and dynamic range. J Clin Lab Anal 1998; 12: 137-44.
9. 9 Price CP, Calvin J, Walker SA, Trull A, Newman DJ, Gorman EG. A rapid and sensitive automated light scattering immunoassay for serum C-reactive protein and the definition of a reference range in healthy blood donors. Clin Chem Lab Med 1999; 37: 109-13.
10. 10 Ledue TB, Weiner DL, Sipe JD, Poulin SE, Collins MF, Rifai N. Analytical evaluation of particle-enhanced immunonephelometric assays for C-reactive protein, serum amyloid A and mannose-binding protein in human serum. Ann Clin Biochem 1998; 35: 745-53.
11. 11 Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, et al. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med 1994; 331: 417-24.
12. 12 Kuller LH, Tracy RP, Shaten J, Meilahn EN. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Am J Epidemiol 1996; 144: 537-47.
13. 13 Haverkate F, Thompson SG, Pyke SDM, Gallimore JR, Pepys MB. Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet 1997; 349: 462-6.
14. 14 Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336: 973-9.
15. 15 Thompson SG, Kienast J, Pyke SD, Haverkate F, van de Loo JC. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. N Engl J Med 1995; 332: 635-41.
16. 16 Whicher JT, Ritchie RF, Johnson AM, Baudner S, Bienvenu J, Blirup-Jensen S, et al. New international reference preparation for proteins in human serum (RPPHS). Clin Chem 1994; 40: 934-8.
17. 17 Glick MR, Ryder KW, Jackson SA. Graphical comparisons of interferences in clinical chemistry instrumentation. Clin Chem 1986; 32: 470-5.
18. 18 Fito M, Biosca C, Hernandez JM, Galimany R. Potential interfering substances on Falcor-600 and Dax-48 analytical systems. Eur J Clin Chem Clin Biochem 1997; 35: 787-92.
19. 19 World Medical Association Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. JAMA 1997; 277: 925-6.
20. 20 Kindmark C-O. The concentration of C-reactive protein in sera from healthy individuals. Scand J Clin Lab Invest 1972; 29: 407-11.
21. 21 Claus DR, Osmand AP, Gewurz H. Radioimmunoassay of human C-reactive protein and levels in normal sera. J Lab Clin Med 1976; 87: 120-8.
22. 22 Ballou SP, Lozanski GB, Hodder S, Rzewnicki DL, Mion LC, Sipe JD, et al. Quantitative and qualitative alterations of acute-phase proteins in healthy elderly persons. Age Ageing 1996; 25: 224-30.
23. 23 Harris EK, Boyd JC. Sample sizes and subgroups. In: Owen DB, Schucany WR, editors. Statistical bases of reference values in laboratory medicine. New York: Marcel Dekker, Inc. 1995: 63-99
24. 24 Palosuo T, Husman T, Koistinen J, Aho K. C-reactive protein in population samples. Acta Med Scand 1986; 220: 175-9.
25. 25 Schwartz MW, Schifreen RS, German E, Tuhy PM, Bienveny J, Warkentin DL. Development and performance of a fully automated method for assay of C-reactive protein in the aca Discrete Clinical Analyzer. Clin Chem 1988; 34: 1646-9.